Susan E. Draheim

889 total citations
21 papers, 727 citations indexed

About

Susan E. Draheim is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Susan E. Draheim has authored 21 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 11 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Susan E. Draheim's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Synthesis and biological activity (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Susan E. Draheim is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Synthesis and biological activity (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Susan E. Draheim collaborates with scholars based in United States. Susan E. Draheim's co-authors include Robert J. Ternansky, Nicholas J. Bach, Robert D. Dillard, David W. Snyder, Lawrence W. Hartley, Edward D. Mihelich, Jean‐Pierre Wery, Richard W. Schevitz, Jennifer L. Olkowski and Cynthia D. Sommers and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Nature Structural & Molecular Biology.

In The Last Decade

Susan E. Draheim

20 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Draheim United States 14 391 289 102 92 61 21 727
Robert D. Dillard United States 16 489 1.3× 406 1.4× 97 1.0× 97 1.1× 69 1.1× 39 980
Ying K. Yee United States 16 275 0.7× 291 1.0× 95 0.9× 78 0.8× 18 0.3× 24 885
Dominick Mobilio United States 9 278 0.7× 132 0.5× 78 0.8× 60 0.7× 85 1.4× 13 544
Émilie Durieu France 18 407 1.0× 313 1.1× 88 0.9× 70 0.8× 27 0.4× 26 874
Feroze Ujjainwalla United States 16 299 0.8× 523 1.8× 108 1.1× 67 0.7× 26 0.4× 28 952
Nicole Caspers United States 15 490 1.3× 231 0.8× 87 0.9× 40 0.4× 53 0.9× 19 809
Philip N. Edwards United Kingdom 15 262 0.7× 239 0.8× 50 0.5× 73 0.8× 73 1.2× 25 588
Steven Fung United States 15 495 1.3× 192 0.7× 71 0.7× 113 1.2× 38 0.6× 24 919
James R. Gillig United States 7 532 1.4× 122 0.4× 91 0.9× 31 0.3× 56 0.9× 9 768
J. Y. GAUTHIER Canada 11 240 0.6× 218 0.8× 118 1.2× 36 0.4× 21 0.3× 20 582

Countries citing papers authored by Susan E. Draheim

Since Specialization
Citations

This map shows the geographic impact of Susan E. Draheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Draheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Draheim more than expected).

Fields of papers citing papers by Susan E. Draheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Draheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Draheim. The network helps show where Susan E. Draheim may publish in the future.

Co-authorship network of co-authors of Susan E. Draheim

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Draheim. A scholar is included among the top collaborators of Susan E. Draheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Draheim. Susan E. Draheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Snyder, David W., Nicholas J. Bach, Robert D. Dillard, et al.. (1999). Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1117–1124. 70 indexed citations
2.
Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1997). ChemInform Abstract: Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. Part 3. Indole‐3‐glyoxamides.. ChemInform. 28(16). 3 indexed citations
3.
Fox, Niles, Min Song, James Schrementi, et al.. (1996). Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors. European Journal of Pharmacology. 308(2). 195–203. 32 indexed citations
4.
Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1996). Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 3. Indole-3-glyoxamides. Journal of Medicinal Chemistry. 39(26). 5159–5175. 76 indexed citations
5.
Fleisch, J H, Edward D. Mihelich, Stephen M. Spaethe, et al.. (1996). Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 252–257. 19 indexed citations
6.
Dillard, Robert D., Nicholas J. Bach, Susan E. Draheim, et al.. (1996). Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 1. Indole-3-acetamides. Journal of Medicinal Chemistry. 39(26). 5119–5136. 64 indexed citations
7.
Schevitz, Richard W., Nicholas J. Bach, Nickolay Y. Chirgadze, et al.. (1995). Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nature Structural & Molecular Biology. 2(6). 458–465. 188 indexed citations
8.
Ternansky, Robert J., Susan E. Draheim, Andrew Pike, et al.. (1993). Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus. Journal of Medicinal Chemistry. 36(14). 1971–1976. 27 indexed citations
9.
Ternansky, Robert J. & Susan E. Draheim. (1993). Structure-activity relationship within a series of pyrazolidinone antibacterial agents. 1. Effect of nuclear modification on in vitro activity. Journal of Medicinal Chemistry. 36(22). 3219–3223. 17 indexed citations
10.
11.
Draheim, Susan E., et al.. (1992). ChemInform Abstract: The Synthesis and Biological Evaluation of Pyrazolidinone Antibacterial Agents. ChemInform. 23(51). 1 indexed citations
12.
Ternansky, Robert J. & Susan E. Draheim. (1992). The chemistry of substituted pyrazolidinones; applications to the synthesis of bicyclic derivatives. Tetrahedron. 48(5). 777–796. 23 indexed citations
13.
Ternansky, Robert J. & Susan E. Draheim. (1990). [3.3.0] Pyrazolodinones: An efficient synthesis of a new class of synthetic antibacterial agents.. Tetrahedron Letters. 31(20). 2805–2808. 28 indexed citations
14.
Draheim, Susan E., et al.. (1988). Oral absorption of cephalosproin antibiotics 2. Expanded structure-activity relationships of 7-arylacetamido-3-substituted cephalosporins. Journal of Medicinal Chemistry. 31(10). 1993–1997. 4 indexed citations
15.
16.
Ternansky, Robert J. & Susan E. Draheim. (1988). [4.3.0] pyrazolidinones as potential antibacterial agents. Tetrahedron Letters. 29(50). 6569–6572. 11 indexed citations
17.
18.
KUKOLJA, S., Susan E. Draheim, David C. Hunden, et al.. (1985). Orally absorbable cephalosporin antibiotics. 2. Structure-activity studies of bicyclic glycine derivatives of 7-aminodeacetoxycephalosporanic acid. Journal of Medicinal Chemistry. 28(12). 1896–1903. 32 indexed citations
19.
20.
KUKOLJA, S., et al.. (1985). Orally absorbable cephalosporin antibiotics. 3. Preparation of biologically active R-isomer of 7-(3-benzothienylglycylamido)deacetoxycephalosporanic acid. Journal of Medicinal Chemistry. 28(12). 1903–1906. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert D. Dillard Breakdown of academic impact, for papers by Ying K. Yee Breakdown of academic impact, for papers by Dominick Mobilio Breakdown of academic impact, for papers by Émilie Durieu Breakdown of academic impact, for papers by Feroze Ujjainwalla Breakdown of academic impact, for papers by Nicole Caspers Breakdown of academic impact, for papers by Philip N. Edwards Breakdown of academic impact, for papers by Steven Fung Breakdown of academic impact, for papers by James R. Gillig Breakdown of academic impact, for papers by J. Y. GAUTHIER
Rankless by CCL
2026